Interestingly, a quantitative assessment using MAnorm revealed that the DM1-CMs showed significantly lower ATAC peaks in the area of DMPK including CTCF binding sites (Fig. 4A,B, +p < 0.01 and *p < 10−5). The gene discussed is DMPK; the disease is myotonic dystrophy type 1.